New handbook on biosimilars

19.09.2014 13:01

Pro Generika, the association of generics and biosimilar companies in Germany, has presented a newly revised version of the handbook on biosimilars.

"Developments in the field of biosimilars are gaining enormous momentum," said Bork Bretthauer, Managing Director of Pro Generika, on the occasion of the publication of the revised Biosimilars Handbook. "Therefore, it was important to us to further develop our 'Biosimilar Handbook' so that physicians, pharmacists, health insurance companies, and patients have an up-to-date reference work that provides them with comprehensive information on the potential of biosimilars for healthcare."

To achieve this goal, objective and comprehensive information is needed for doctors, associations of statutory health insurance physicians, health insurance funds and pharmacists about the safety and efficacy of biosimilars proven by the approval as well as about their use in healthcare, according to the press release from Pro Generika.

An electronic version of the manual can be found at: http://www.progenerika.de/publikationen/biosimilars-ein-handbuch-september-2014/

A printed copy can be obtained from [email protected] be ordered.